Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:WLL-vs
go back to main search page
Accession:CHEBI:91210 term browser browse the term
Definition:A dipeptide that is L-tryptophyl-L-leucinamide in which the N-terminal amino group has been converted to the corresponding (morpholin-4-yl)acetamide and in which one of the hydrogens attached to the nitrogen of the C-terminal amide has been replaced by a (1E)-5-methyl-1-(methylsulfonyl)hex-1-en-3-yl group. It is a selective proteasome inhibitor.
Synonyms:exact_synonym: N-(morpholin-4-ylacetyl)-L-tryptophyl-N-[(1E,3S)-5-methyl-1-(methylsulfonyl)hex-1-en-3-yl]-L-leucinamide
 related_synonym: Formula=C31H47N5O6S;   InChI=1S/C31H47N5O6S/c1-21(2)16-24(10-15-43(5,40)41)33-30(38)27(17-22(3)4)35-31(39)28(34-29(37)20-36-11-13-42-14-12-36)18-23-19-32-26-9-7-6-8-25(23)26/h6-10,15,19,21-22,24,27-28,32H,11-14,16-18,20H2,1-5H3,(H,33,38)(H,34,37)(H,35,39)/b15-10+/t24-,27+,28+/m1/s1;   InChIKey=DKBAFRHAWTVKAD-ODGLJRBPSA-N;   SMILES=C(\\[C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC=1C2=CC=CC=C2NC1)NC(=O)CN3CCOCC3)=O)=O)=C/S(C)(=O)=O
 xref: PMID:26863983


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 844
    role 821
      application 460
        pharmaceutical 409
          drug 409
            proteasome inhibitor 4
              WLL-vs 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 844
    subatomic particle 828
      composite particle 828
        hadron 828
          baryon 828
            nucleon 828
              atomic nucleus 828
                atom 828
                  main group element atom 816
                    p-block element atom 813
                      carbon group element atom 784
                        carbon atom 780
                          organic molecular entity 780
                            organic group 360
                              organic divalent group 358
                                organodiyl group 358
                                  carbonyl group 357
                                    carbonyl compound 357
                                      carboxylic acid 241
                                        carboacyl group 155
                                          univalent carboacyl group 155
                                            carbamoyl group 152
                                              carboxamide 152
                                                peptide 36
                                                  oligopeptide 11
                                                    dipeptide 3
                                                      Trp-Leu 0
                                                        WLL-vs 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.